Regimmune raises $5 million as RGI-2001 enters Phase I/II

Autoimmune and allergy company Regimmune Corp. (Tokyo, Japan) raised $5 million in the first tranche of a preferred series A round co-led by Daiwa Enterprise Co. Ltd. and Japan Asia Investment Corp. (...